During Wednesday's trading session, the S&P 500 and Nasdaq Composite seemed to take a breather from their recent rally. The broad market index closed 0.38% lower, while the Nasdaq fell by 1.29%. The Dow 30 stocks bucked the trend with a modest gain of 0.27% or 91.74 points. Our robots closed with mixed results yesterday. The banking sector showed strong growth, leading the market. However, technology stocks experienced a correction after a prolonged period of gains. We view this correction as an opportunity to accumulate positions ahead of further growth.
Investors appear to be in a wait-and-see mode, anticipating the upcoming Federal Reserve policy meeting on June 13th and 14th. Economic indicators suggest that inflation is slowly easing, even though it remains above the central bank's target of 2%. For instance, wage growth is slowing down. According to Indeed data, average wages grew by 5.3% year-on-year in May, a 0.4 percentage point decrease compared to April.
According to the CME FedWatch Tool, markets are pricing in a 66% probability that the Fed will keep interest rates unchanged at the next meeting.
Additional economic data will be released on Thursday morning, including weekly jobless claims and wholesale inventories.
BAC stock looks promising for further growth. The RSI Indicator suggests an upward trend with a 62% probability. The Momentum Indicator, MACD, and moving averages also indicate potential upward movement. Recent 3-day advances have historically resulted in continued price growth with a 61% probability.
The 50-day moving average for BAC moved above the 200-day moving average on June 05, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 273 cases where BAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for BAC moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BAC broke above its upper Bollinger Band on July 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. BAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 23, placing this stock slightly worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.501) is normal, around the industry mean (1.900). P/E Ratio (14.467) is within average values for comparable stocks, (15.571). Projected Growth (PEG Ratio) (1.037) is also within normal values, averaging (1.728). Dividend Yield (0.019) settles around the average of (0.026) among similar stocks. P/S Ratio (3.845) is also within normal values, averaging (4.027).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks